Royal Bank of Canada
ALGS icon

Royal Bank of Canada’s Aligos Therapeutics ALGS Stock Holding History

Royal Bank of Canada’s Portfolio ALGS Stock Details ALGS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$16K Hold
2,125
– – ﹤0.01% 5980
2025
Q4 		$20K Hold
2,125
– – ﹤0.01% 6031
2025
Q3 		$21K Hold
2,125
– – ﹤0.01% 6186
2025
Q2 		$15K Hold
2,125
– – ﹤0.01% 6348
2025
Q1 		$18K Sell
2,125
-20,883
-91% -$458K ﹤0.01% 5948
2024
Q4 		$916K Buy
+23,008
New +$445K ﹤0.01% 3606
2024
Q3 		– Sell
-20
Closed – – 6801
2024
Q2 		$0 Buy
20
+15
+300% +$264 ﹤0.01% 6991
2024
Q1 		$0 Sell
5
-13
-72% -$259 ﹤0.01% 6965
2023
Q4 		$0 Sell
18
-25,764
-100% -$443K ﹤0.01% 7068
2023
Q3 		$481K Sell
25,782
-7,834
-23% -$174K ﹤0.01% 4067
2023
Q2 		$816K Buy
33,616
+31,827
+1,779% +$854K ﹤0.01% 3545
2023
Q1 		$39K Buy
1,789
+1,788
+178,800% +$68.3K ﹤0.01% 5747
2022
Q4 		$0 Hold
1
– – ﹤0.01% 7179
2022
Q3 		$0 Hold
1
– – ﹤0.01% 7406
2022
Q2 		$0 Sell
1
-51
-98% -$1.73K ﹤0.01% 7330
2022
Q1 		$3K Sell
52
-122
-70% -$9.77K ﹤0.01% 7371
2021
Q4 		$52K Buy
174
+103
+145% +$37.6K ﹤0.01% 6350
2021
Q3 		$27K Buy
71
+20
+39% +$7.91K ﹤0.01% 6512
2021
Q2 		$26K Buy
51
+26
+104% +$16.6K ﹤0.01% 6413
2021
Q1 		$14K Buy
25
+3
+14% +$2K ﹤0.01% 6627
2020
Q4 		$15K Buy
+22
New +$10.7K ﹤0.01% 6183

Other funds holding ALGS

DTC
Deep Track Capital Greenwich, Connecticut $6.12B AUM 144% 1-Year Est. Return
Alyeska Investment Group
Alyeska Investment Group Chicago, Illinois $35.4B AUM 33.54% 1-Year Est. Return
SCM
Sio Capital Management New York $697M AUM 79.73% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
WP
Woodline Partners San Francisco, California $26.4B AUM 44.85% 1-Year Est. Return
SC
SummitTX Capital Fort Worth, Texas $3.2B AUM 41.22% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return

Royal Bank of Canada's ALGS Position: Q1 2026 in Review

Royal Bank of Canada held its Aligos Therapeutics (ALGS) position steady in Q1 2026 at 2,125 shares worth $16K. The position accounts for ﹤0.01% of the portfolio, ranked #5980.

Royal Bank of Canada first reported a position in ALGS in Q4 2020 and has held it in 21 quarters since. The position peaked at $916K in Q4 2024. 35 funds tracked by Wall St. Rank hold ALGS as of Q1 2026.

  • Royal Bank of Canada held 2,125 shares of Aligos Therapeutics worth $16K as of Q1 2026.
  • Royal Bank of Canada left its Aligos Therapeutics share count unchanged in Q1 2026.
  • Aligos Therapeutics made up ﹤0.01% of Royal Bank of Canada's portfolio in Q1 2026, its #5980 holding.
  • Royal Bank of Canada first reported a position in Aligos Therapeutics in Q4 2020 and has held it in 21 quarters since.
  • Royal Bank of Canada's Aligos Therapeutics position peaked at $916K in Q4 2024.
  • 35 funds tracked by Wall St. Rank held Aligos Therapeutics as of Q1 2026.

Based on Royal Bank of Canada's 13F filing for Q1 2026, filed 15 May 2026.